cancer

New study of FDA cites the flaws behind rapid-fire cancer drug OKs
Endpoints
Wed, 08/16/17 - 11:14 am
FDA
drug approvals
cancer
oncology
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
NY Times, NY
Mon, 08/14/17 - 09:30 pm
cancer
oncology
clinical trials
patients
Ending the era of $100,000 cancer drugs
Pharmafile
Sat, 08/12/17 - 12:08 pm
cancer
drug pricing
oncology
Making the Promise of Immunotherapeutics into Reality
Elsevier
Tue, 08/8/17 - 11:29 am
immunotherapy
cancer
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
Endpoints
Wed, 07/26/17 - 09:52 am
GSK
reorganization
Emma Walmsley
Pharma CEOs
R&D
cancer
The Startling History Behind Merck's New Cancer Blockbuster
Forbes
Wed, 07/26/17 - 09:51 am
Merck
Keytruda
cancer
R&D
Organon
King cancer: The top 10 therapeutic areas in biopharma R&D
Endpoints
Tue, 07/18/17 - 10:49 pm
R&D
cancer
neurology
infection
immunology
cardiovascular disease
diabetes
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
Thu, 07/13/17 - 09:03 am
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
How Reproducible are Preclinical Study Results?
Xtalks
Mon, 07/10/17 - 11:43 am
preclinical study results
cancer
oncology
clinical trials
Marketing cancer drugs is costly, but pharma has room for savings: report
Fierce Pharma
Mon, 07/10/17 - 11:10 am
pharma marketing
cancer
Personalized cancer vaccines vanquish melanoma in small but encouraging study
Stat
Wed, 07/5/17 - 07:04 pm
personalized medicine
cancer
vaccines
melanoma
Keytruda
Merck
Neon Therapeutics
Two cancer drug prices have already been hiked by 8% this year
Marketwatch
Wed, 07/5/17 - 09:35 am
drug pricing
cancer
Amgen
Blincyto
Teva Pharmaceutical
Treanda
lymphoma
leukemia
Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs
Xconomy
Wed, 06/28/17 - 09:50 am
Vivace Therapeutics
cancer
Standing out in crowded cancer market
Medical Marketing and Media
Mon, 06/26/17 - 10:36 pm
cancer
Opdivo
Bristol-Myers Squibb
FDA to Clear Path for Drugs Aimed at Cancer-Causing Genes
Bloomberg
Wed, 06/21/17 - 07:42 pm
FDA
gene therapy
tumor-agnostic therapies
cancer
Scott Gottlieb
Cancer's Big Infrastructure Problem
Forbes
Sat, 06/17/17 - 07:20 pm
cancer
oncology
personalized medicine
clinical trials
clinical trial data
Novartis’s Next Challenge: Pricing Breakthrough Cancer Treatment
Bloomberg
Thu, 06/8/17 - 10:24 pm
Novartis
drug pricing
CTL019
cancer
CAR-T
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
Yahoo/CNBC
Wed, 06/7/17 - 10:11 am
patients
cancer
Bristol-Myers Squibb
drug pricing
ASCO 2017
Giovanni Caforio
A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us
Forbes
Sun, 06/4/17 - 11:40 am
cancer
oncology
larotrectinib
Loxo Oncology
clinical trials
patients

Pages